In early-stage ovarian cancer, the sensitivity and specificity of HE4 were 0.64 and 0.87, respectively, and HE4 performed better than CA125 concerning the specificity (97% vs. 67%) [99,100]. The gene discussed is MUC16; the disease is ovarian cancer.